BioClinica Partners with Paragon Solutions to Create Clinical Architecture

NEWTOWN, Pa.--(BUSINESS WIRE)--

BioClinica^®, Inc. BIOC, a global provider of clinical trial management solutions, today announced its partnership with Paragon Solutions, an advisory consulting and systems integration firm that specializes in enterprise information management. BioClinica customers will utilize Paragon's resources and expertise to support large-scale integration of BioClinica's eClinical solutions across a variety of technology partnerships and client implementations.

The Paragon partnership will play a key role in BioClinica's plans to enhance operational data management by uniting its OnPoint CTMS with NextDocs' eTMF document management through a SharePoint-based Clinical Reference Architecture. By leveraging the benefits of SharePoint technology, this solution simplifies the consolidation and integration of operational data from and between CTMS, EDC, IVRS, eTMF and Clinical Portals to offer a cost-effective, unified study management environment.

BioClinica OnPoint CTMS helps clinical trial sponsors and CROs to efficiently access, share, and analyze operational data by leveraging the power and ease of use of Microsoft SharePoint. NextDocs' eTMF provides customers with a comprehensive document repository that simplifies the management of essential trial documentation and is compliant with the established Drug Information Association (DIA) reference model. Paragon will provide the clinical data architecture to bridge the gap between systems to create operational efficiencies such as the elimination of redundant data entry.

“The best clinical trial solutions come from companies who specialize,” said Peter Benton, BioClinica's President of eClinical Solutions. “The BioClinica/Paragon clinical data integration platform enables trial sponsors to pair cutting-edge eClinical solutions with specialized, regulatory-compliant document management services to create a clinical trial solution that unifies the top technologies in the industry.”

“Paragon's subject matter knowledge of clinical trial processes and data requirements, coupled with leading technology provider BioClinica's product capabilities, establishes a platform that provides a robust clinical architecture for our clients,” said Ravi Shankar, senior vice president, life sciences and healthcare for Paragon.

Both BioClinica and Paragon are Microsoft Certified Partners. BioClinica is known for its industry-leading integration with Microsoft technology, harnessing the power of SharePoint and the Microsoft Office Suite to provide study project managers a comprehensive, real-time view into trial performance.

Follow BioClinica on the Trial Blazers blog at http://info.bioclinica.com/blog, and on Twitter at http://twitter.com/bioclinica.

About BioClinica, Inc.

BioClinica, Inc. is a leading global provider of integrated, technology-enhanced clinical trial management solutions. BioClinica supports pharmaceutical and medical device innovation with imaging core lab, internet image transport, electronic data capture, interactive voice and web response, clinical trial management and clinical supply chain design and optimization solutions. BioClinica solutions maximize efficiency and manageability throughout all phases of the clinical trial process. With over 20 years of experience and more than 2,000 successful trials to date, BioClinica has supported the clinical development of many new medicines from early phase trials through final approval. BioClinica operates state-of-the-art, regulatory-body-compliant imaging core labs on two continents, and supports worldwide eClinical and data management services from offices in the United States, Europe and Asia. For more information, please visit www.bioclinica.com

About Paragon

Paragon Solutions is an advisory consulting and systems integration firm that specializes in enterprise information management to help clients leverage information assets for better business results. The company does this through its industry practices, solution accelerators and specialized technology competencies that help clients achieve operational efficiency, business scalability and regulatory compliance. Paragon works with businesses that are focused in a few key industries − communications, financial services, healthcare, insurance, and life sciences. The industry-focused practices work with Paragon's competency groups to address today's client concerns in Process Optimization, Information Management and Information Insight. For more information, please visit the Paragon website at http://www.consultparagon.com or call 1.800.462.5582

Certain matters discussed in this press release are “forward-looking statements” intended to qualify for the safe harbors from liability established by the Private Securities Litigation Reform Act of 1995. In particular, the Company's statements regarding trends in the marketplace and potential future results are examples of such forward-looking statements. The forward-looking statements include risks and uncertainties, including, but not limited to, the consummation and the successful integration of current and proposed acquisitions, the timing of projects due to the variability in size, scope and duration of projects, estimates and guidance made by management with respect to the Company's financial results, backlog, critical accounting policies, regulatory delays, clinical study results which lead to reductions or cancellations of projects, and other factors, including general economic conditions and regulatory developments, not within the Company's control. The factors discussed herein and expressed from time to time in the Company's filings with the Securities and Exchange Commission could cause actual results and developments to be materially different from those expressed in or implied by such statements. The forward-looking statements are made only as of the date of this press release and the Company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstance. You should review the Company's filings, especially risk factors contained in the Form 10-K and the recent Form 10-Q.